Infectious Disease
Neonatal Sepsis
15
Pipeline Programs↗
2
Active Trials↗
10
Companies Involved↗
Neonatal sepsis is an emerging landscape with 15 programs across 10 companies. The most active players are AstraZeneca, Neurim Pharmaceuticals Ltd., Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. 6 therapies are approved with 5 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 2
No programs
Phase 35
Analysis
Trial Status
14
clinical trials
Completed8 · 57%
Unknown status4 · 29%
Not yet recruiting2 · 14%
Clinical Trials
Trial Activity
14 trials
Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis
Not yet recruiting·—·Phase 3·NCT07380347·50 enrolled
Role of Vitamin D Therapy in Recovery From Early Neonatal Sepsis (Randomized Controlled Trial)
Completed·—·Phase 3·NCT05969327·66 enrolled
Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis
Completed·—·Phase 4·NCT02959229·180 enrolled
Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
Completed·—·Phase 1/2·NCT03295162·55 enrolled
Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'
Unknown status·ZZekai Tahir Burak Women's Health Research and Education Hospital·Phase 4·NCT01006499·204 enrolled
Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal Sepsis
Unknown status·—·N/A·NCT05742477·100 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)